26d agoThe FlyBULLISH 69Analyst
Archived explainer. For the current picture see today's PRAX page.
Why Is PRAXIS PRECISION MED (PRAX) Stock Up Today?
By the Top Tier Newswire AI Desk · August 17, 2026 at 1:18 PM ET · reviewed against 2 wire stories
PRAXIS PRECISION MED (PRAX) is up +6.37% in the latest session. Our newswire has captured 2 stories on PRAX across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 65/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why PRAX stock is up today
PRAX stock surged 6.37% to $390.19 in a single session driven by a price target increase from Raymond James. The stock opened at $367.50 and climbed to a high of $391.64 before settling near the high at $390.00. The move reflects growing optimism around the company's pipeline outlook.
What Happened
Raymond James raised its price target for Praxis Precision Medicines from $765 to $945. This action was cited as a key factor in the stock's performance. Additional upgrades from RBC Capital, Wells Fargo, and Needham also contributed to the positive momentum. RBC Capital raised its price target to $462, while Wells Fargo set its target at $362 and Needham at $582. These analyst actions underscored a broader trend of increased confidence in the company's prospects.
What The Data Shows
The stock has shown strong performance over the past eight sessions, rising 14.2% from $319.23 to $364.44. The current session saw volume of 0.2 million shares, which is 0.4 times the 3-month daily average. The stock is trading near its 52-week high of $388.00 and has printed 23 fresh 52-week highs on August 17, 2026. Despite a market cap of $10.1 billion, the company remains unprofitable with an EPS of -12.86 for the trailing twelve months. Revenue, however, has grown by 365.0% over the same period.
What To Watch
The stock is set to continue under the microscope as coverage breadth expands. Investors may also watch for future earnings releases and further analyst commentary on the company's pipeline developments.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
PRAX by the numbers
Last: $390.19Session: +6.37%7 sessions: +1.17%Coverage: 2 stories / 2 sourcesAI sentiment: 65/100 (bullish)Mkt cap: $10.1B52w: $37.19 to $388.00
The headlines behind the move
27d agoInvesting.com Analyst RatingsBULLISH 61Analyst
Raymond James raises Praxis Precision Medicines price target on pipeline outlook
Raymond James raises Praxis Precision Medicines price target on pipeline outlook
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on PRAX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier PRAX move explainers: 2026-08-17 · 2026-08-07 · 2026-08-06